Concepedia

Yanai Zhan

YZ

16

Publications

1.4K

Citations

16

H-Index

2004

Active since

Affiliations

Incell Corporation (United States)(Current)

Beth Israel Deaconess Medical Center

Harvard University

The University of Texas MD Anderson Cancer Center

Harvard University Press

Yanai Zhan is an author at Incell Corporation (United States) specializing in medicine, cell biology, and tumor microenvironment.

Top concepts

MedicineCell BiologyImmunologyLung CancerTumor BiologyCell SignalingCancer ResearchSystems BiologyNatural SciencesMolecular Biology

Publications per year

2004–2018

16

Publications

16

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

Bhavatarini Vangamudi, Thomas A. Paul, Parantu K. Shah et al. · Cancer Research · 2015 · 266 citations · Full text

Atpase Domain, Exclusive Catalytic Subunits, Drug Target +17

Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer

María Angélica Cortez, David R. Valdecanas, Xiaochun Zhang et al. · Molecular Therapy · 2014 · 192 citations · Full text

Mir-200 Mirnas, Oncogenic Agent, Medicine +14

Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor

Wylie S. Palmer, G. Poncet-Montange, Gang Liu et al. · Journal of Medicinal Chemistry · 2015 · 152 citations · Full text

Combinatorial Chemistry, Epigenetic Change, X-ray Cocrystal Structures +20

Substance P mediates antiapoptotic responses in human colonocytes by Akt activation

Hon-Wai Koon, Dezheng Zhao, Yanai Zhan et al. · Proceedings of the National Academy of Sciences · 2007 · 103 citations · Full text

Substance P Stimulates Cyclooxygenase-2 and Prostaglandin E2 Expression through JAK-STAT Activation in Human Colonic Epithelial Cells

Hon–Wai Koon, Dezheng Zhao, Yanai Zhan et al. · The Journal of Immunology · 2006 · 102 citations · Full text

Rows per page

1–5 of 16